_id

690db1c3ccc777a4e85d0c14

Ticker

ASMB

Name

Assembly Biosciences Inc

Exchange

NASDAQ

Address

Two Tower Place, South San Francisco, CA, United States, 94080

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.assemblybio.com

Description

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5336 and ABI-1179, which are in Phase 1a/1b clinical studies for recurrent genital herpes; ABI-4334, a capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus that is in Phase 1b clinical study; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study. The company also develops ABI-7423, an oral broad-spectrum non-nucleoside polymerase inhibitor that targets transplant-related herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Last Close

35.88

Volume

61184

Current Price

36.1

Change

0.6131549609810447

Last Updated

2025-11-28T12:26:59.484Z

Image

-

Ipo Date

2010-12-17T00:00:00.000Z

Market Cap

588239424

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9979999999999999

Sentiment Sources

3

Rating

5

Target Price

40.4

Strong Buy

2

Buy

0

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

10789000

Cost Of Revenue

-

Gross Profit

10789000

Operating Expenses

21672000

Operating Income

-10883000

Interest Expense

-

Pretax Income

-9196000

Net Income

-9196000

Eps

-1.2011723316562724

Dividends Per Share

-

Shares Outstanding

15817140

Income Tax Expense

-

EBITDA

-9164000

Operating Margin

-100.87125776253592

Total Other Income Expense Net

1687000

Cash

22534000

Short Term Investments

210023000

Receivables

912000

Inventories

-

Total Current Assets

236812000

Property Plant Equipment

2873000

Total Assets

239997000

Payables

1683000

Short Term Debt

548000

Long Term Debt

-

Total Liabilities

57302000

Equity

182695000

Depreciation

32000

Change In Working Capital

-7217000

Cash From Operations

-15133000

Capital Expenditures

42000

Cash From Investing

-158271000

Cash From Financing

171932000

Net Change In Cash

-1472000

PE

-

PB

1.5127744568816883

ROE

-5.033525821724733

ROA

-3.8317145630987053

FCF

-15175000

Fcf Percent

-1.406525164519418

Piotroski FScore

0

Health Score

34

Deep Value Investing Score

3

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

3.5

Growth Investing Score

2

Momentum Investing Score

2

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

4.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

10789000

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

10789000

Quarters > 0 > income Statement > operating Expenses

21672000

Quarters > 0 > income Statement > operating Income

-10883000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-9196000

Quarters > 0 > income Statement > net Income

-9196000

Quarters > 0 > income Statement > eps

-1.2011723316562724

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

7655854

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-9164000

Quarters > 0 > income Statement > operating Margin

-100.87125776253592

Quarters > 0 > income Statement > total Other Income Expense Net

1687000

Quarters > 0 > balance Sheet > cash

22534000

Quarters > 0 > balance Sheet > short Term Investments

210023000

Quarters > 0 > balance Sheet > receivables

912000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

236812000

Quarters > 0 > balance Sheet > property Plant Equipment

2873000

Quarters > 0 > balance Sheet > total Assets

239997000

Quarters > 0 > balance Sheet > payables

1683000

Quarters > 0 > balance Sheet > short Term Debt

548000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

57302000

Quarters > 0 > balance Sheet > equity

182695000

Quarters > 0 > cash Flow > net Income

-9196000

Quarters > 0 > cash Flow > depreciation

32000

Quarters > 0 > cash Flow > change In Working Capital

-7217000

Quarters > 0 > cash Flow > cash From Operations

-15133000

Quarters > 0 > cash Flow > capital Expenditures

42000

Quarters > 0 > cash Flow > cash From Investing

-158271000

Quarters > 0 > cash Flow > cash From Financing

171932000

Quarters > 0 > cash Flow > net Change In Cash

-1472000

Quarters > 0 > ratios > PE

-1.2011723316562724

Quarters > 0 > ratios > PB

1.5127744568816883

Quarters > 0 > ratios > ROE

-5.033525821724733

Quarters > 0 > ratios > ROA

-3.8317145630987053

Quarters > 0 > ratios > FCF

-15175000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-1.406525164519418

Quarters > 0 > health Score

34

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

9626000

Quarters > 1 > income Statement > cost Of Revenue

16125000

Quarters > 1 > income Statement > gross Profit

-6499000

Quarters > 1 > income Statement > operating Expenses

4594000

Quarters > 1 > income Statement > operating Income

-11093000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-10198000

Quarters > 1 > income Statement > net Income

-10198000

Quarters > 1 > income Statement > eps

-1.332052570490503

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

7655854

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-11061000

Quarters > 1 > income Statement > operating Margin

-115.23997506752546

Quarters > 1 > income Statement > total Other Income Expense Net

895000

Quarters > 1 > balance Sheet > cash

24006000

Quarters > 1 > balance Sheet > short Term Investments

50974000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

77467000

Quarters > 1 > balance Sheet > property Plant Equipment

3001000

Quarters > 1 > balance Sheet > total Assets

80780000

Quarters > 1 > balance Sheet > payables

743000

Quarters > 1 > balance Sheet > short Term Debt

533000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

62680000

Quarters > 1 > balance Sheet > equity

18100000

Quarters > 1 > cash Flow > net Income

-10198000

Quarters > 1 > cash Flow > depreciation

32000

Quarters > 1 > cash Flow > change In Working Capital

-7266000

Quarters > 1 > cash Flow > cash From Operations

-16758000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

16994000

Quarters > 1 > cash Flow > cash From Financing

357000

Quarters > 1 > cash Flow > net Change In Cash

593000

Quarters > 1 > ratios > PE

-1.332052570490503

Quarters > 1 > ratios > PB

15.269410464088399

Quarters > 1 > ratios > ROE

-56.34254143646409

Quarters > 1 > ratios > ROA

-12.62441198316415

Quarters > 1 > ratios > FCF

-16758000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-1.7409100353210056

Quarters > 1 > health Score

8

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

9419000

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

9419000

Quarters > 2 > income Statement > operating Expenses

19360000

Quarters > 2 > income Statement > operating Income

-9941000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-8818000

Quarters > 2 > income Statement > net Income

-8818000

Quarters > 2 > income Statement > eps

-1.1747432597140464

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

7506321

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-9908000

Quarters > 2 > income Statement > operating Margin

-105.54198959549845

Quarters > 2 > income Statement > total Other Income Expense Net

1123000

Quarters > 2 > balance Sheet > cash

23413000

Quarters > 2 > balance Sheet > short Term Investments

67615000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

95527000

Quarters > 2 > balance Sheet > property Plant Equipment

3178000

Quarters > 2 > balance Sheet > total Assets

99017000

Quarters > 2 > balance Sheet > payables

875000

Quarters > 2 > balance Sheet > short Term Debt

529000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

71884000

Quarters > 2 > balance Sheet > equity

27133000

Quarters > 2 > cash Flow > net Income

-8818000

Quarters > 2 > cash Flow > depreciation

33000

Quarters > 2 > cash Flow > change In Working Capital

-15077000

Quarters > 2 > cash Flow > cash From Operations

-23439000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

6586000

Quarters > 2 > cash Flow > cash From Financing

1922000

Quarters > 2 > cash Flow > net Change In Cash

-14931000

Quarters > 2 > ratios > PE

-1.1747432597140464

Quarters > 2 > ratios > PB

9.987033800169536

Quarters > 2 > ratios > ROE

-32.49917075148343

Quarters > 2 > ratios > ROA

-8.90554147267641

Quarters > 2 > ratios > FCF

-23439000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-2.4884807304384755

Quarters > 2 > health Score

12

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

7357000

Quarters > 3 > income Statement > cost Of Revenue

14280000

Quarters > 3 > income Statement > gross Profit

-6923000

Quarters > 3 > income Statement > operating Expenses

4609000

Quarters > 3 > income Statement > operating Income

-11532000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-10259001

Quarters > 3 > income Statement > net Income

-10335000

Quarters > 3 > income Statement > eps

-1.5704090265925634

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

6581088

Quarters > 3 > income Statement > income Tax Expense

75999

Quarters > 3 > income Statement > EBITDA

-11500000

Quarters > 3 > income Statement > operating Margin

-156.7486747315482

Quarters > 3 > income Statement > total Other Income Expense Net

1272999

Quarters > 3 > balance Sheet > cash

38344000

Quarters > 3 > balance Sheet > short Term Investments

73735000

Quarters > 3 > balance Sheet > receivables

400000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

115503000

Quarters > 3 > balance Sheet > property Plant Equipment

3353000

Quarters > 3 > balance Sheet > total Assets

119168000

Quarters > 3 > balance Sheet > payables

585000

Quarters > 3 > balance Sheet > short Term Debt

461000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

85809000

Quarters > 3 > balance Sheet > equity

33359000

Quarters > 3 > cash Flow > net Income

-10335000

Quarters > 3 > cash Flow > depreciation

32000

Quarters > 3 > cash Flow > change In Working Capital

9385000

Quarters > 3 > cash Flow > cash From Operations

-407000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-6696000

Quarters > 3 > cash Flow > cash From Financing

16995000

Quarters > 3 > cash Flow > net Change In Cash

9892000

Quarters > 3 > ratios > PE

-1.5704090265925634

Quarters > 3 > ratios > PB

7.121834491441591

Quarters > 3 > ratios > ROE

-30.981144518720583

Quarters > 3 > ratios > ROA

-8.672630236305048

Quarters > 3 > ratios > FCF

-407000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.055321462552670925

Quarters > 3 > health Score

13

Valuation > metrics > PE

-1.2011723316562724

Valuation > metrics > PB

1.5127744568816883

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-5.033525821724733

Profitability > metrics > ROA

-3.8832491596709624

Profitability > metrics > Net Margin

-0.8523496153489666

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.31364843044418295

Risk > metrics > Interest Coverage

-340.09375

Risk > final Score

-1300

Risk > verdict

High

Liquidity > metrics > Current Ratio

106.14612281488122

Liquidity > metrics > Quick Ratio

106.14612281488122

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-45

Prev Risks > 1

-18

Prev Risks > 2

-19

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:14:39.881Z